Latest News

Experimental drug reduces brain damage, eliminates brain hemorrhaging in rodents afflicted by stroke

The experimental drug 3K3A-APC shows promise as a stand-alone therapy for stroke or in combination with the FDA-approved clot-busting drug therapy tPA (tissue plasminogen activator).
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Intervention helps smokers quit following hospital stay

  • Employee-retention practices challenged by experts

  • Recovery reversal seen in study of returning concussed athletes

  • Colds and other common infections tied to some stroke risk in kids

  • Striatum acts as hub for multisensory integration

  • Forensics research to make cadaver dogs more efficient

  • Study Identifies Challenges Faced by NYU Langone Nurses in the Aftermath of Hurricane Sandy

  • Creating pomegranate drug to stem Alzheimer's, Parkinson's

  • In our digital world, are young people losing the ability to read emotions?

  • Use rule of thumb to control how much you drink

  •